Bender Robert & Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$18.5K | – | 56 |
|
|
2023
Q1 | $18.5K | Buy |
+10,000
| New | +$18.5K | 0.01% | 54 |
|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$23K | – | 55 |
|
|
2022
Q3 | $23K | Hold |
10,000
| – | – | 0.01% | 52 |
|
|
2022
Q2 | $30K | Buy |
+10,000
| New | +$30K | 0.01% | 53 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$103K | – | 56 |
|
|
2021
Q1 | $103K | Buy |
+10,000
| New | +$103K | 0.03% | 54 |
|